134 related articles for article (PubMed ID: 34843107)
1. Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
Du Y; Khera T; Strunz B; Deterding K; Todt D; Woller N; Engelskircher SA; Hardtke S; Port K; Ponzetta A; Steinmann E; Cornberg M; Hengst J; Björkström NK; Wedemeyer H;
Eur J Immunol; 2022 Mar; 52(3):472-483. PubMed ID: 34843107
[TBL] [Abstract][Full Text] [Related]
2. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
3. Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.
Khlaiphuengsin A; Chuaypen N; Sodsai P; Reantragoon R; Han WM; Avihingsanon A; Tangkijvanich P
PLoS One; 2020; 15(12):e0244112. PubMed ID: 33382729
[TBL] [Abstract][Full Text] [Related]
4. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
[TBL] [Abstract][Full Text] [Related]
5. MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection.
Hofmann M; Thimme R
Eur J Immunol; 2016 Sep; 46(9):2099-102. PubMed ID: 27479232
[TBL] [Abstract][Full Text] [Related]
6. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
Front Immunol; 2019; 10():1926. PubMed ID: 31456810
[TBL] [Abstract][Full Text] [Related]
7. In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
Telatin V; Nicoli F; Frasson C; Menegotto N; Barbaro F; Castelli E; Erne E; Palù G; Caputo A
Front Cell Infect Microbiol; 2019; 9():190. PubMed ID: 31259160
[TBL] [Abstract][Full Text] [Related]
8. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
9. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
10. Peripheral PD-1
Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
Front Immunol; 2019; 10():1470. PubMed ID: 31316516
[TBL] [Abstract][Full Text] [Related]
11. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.
Hengst J; Strunz B; Deterding K; Ljunggren HG; Leeansyah E; Manns MP; Cornberg M; Sandberg JK; Wedemeyer H; Björkström NK
Eur J Immunol; 2016 Sep; 46(9):2204-10. PubMed ID: 27296288
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection.
Han JW; Sung PS; Kim KH; Hong SH; Shin EC; Jun Song M; Park SH
J Infect Dis; 2019 Sep; 220(8):1290-1301. PubMed ID: 31152667
[TBL] [Abstract][Full Text] [Related]
13. IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses.
Han JW; Sung PS; Hong SH; Lee H; Koh JY; Lee H; White S; Maslow JN; Weiner DB; Park SH; Jeong M; Heo J; Ahn SH; Shin EC
J Hepatol; 2020 Jul; 73(1):72-83. PubMed ID: 32088322
[TBL] [Abstract][Full Text] [Related]
14. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of CD8
Lu X; Song B; Weng W; Su B; Wu H; Cheung AKL; Zhang T; Gao Y
Viral Immunol; 2023 Jan; 36(1):25-32. PubMed ID: 36346310
[TBL] [Abstract][Full Text] [Related]
16. Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?
Wedemeyer H; Khera T; Strunz B; Björkström NK
Front Immunol; 2020; 11():571166. PubMed ID: 33133084
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.
Casey JL; Dore GJ; Grebely J; Matthews GV; Cherepanov V; Martinello M; Marks P; Janssen HLA; Hansen BE; Kaul R; MacParland SA; Gehring AJ; Feld JJ
J Viral Hepat; 2023 Jan; 30(1):64-72. PubMed ID: 36302162
[TBL] [Abstract][Full Text] [Related]
18. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J; Heinonen T; Fenwick C; Schrijver IT; Ohmiti K; Moradpour D; Cavassini M; Pantaleo G; Roger T; Calandra T;
Clin Microbiol Infect; 2022 Apr; 28(4):611.e1-611.e7. PubMed ID: 34474121
[TBL] [Abstract][Full Text] [Related]
19. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
[TBL] [Abstract][Full Text] [Related]
20. Reversal of T Cell Exhaustion in Chronic HCV Infection.
Osuch S; Metzner KJ; Caraballo Cortés K
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
